Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Vanguard Study: Testing a New Way to Screen for Cancer

NCT06995898 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT06995898
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06995898 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Vanguard Study: Testing a New Way to Screen for Cancer
Lead sponsor
National Cancer Institute (NCI)
Phase
Not applicable
Overall status
Recruiting
Start date
June 18, 2025
Completion date
June 30, 2029
Enrollment
24,000 (estimated)
Sites
45

Conditions

As the registry lists them; a condition with its own page is linked.

bladder carcinoma, breast carcinoma, colorectal carcinoma, esophageal carcinoma, gastric carcinoma, liver carcinoma, lung carcinoma, malignant solid neoplasm, ovarian carcinoma, pancreatic carcinoma, prostate carcinoma